Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of curcumin on glioblastoma cells
Amireza Hesari, Marzieh Rezaei, Maryam Rezaei, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 10281-10288
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis
Tzu-Chi Chen, Jian‐Ying Chuang, Chiung-Yuan Ko, et al.
Redox Biology (2019) Vol. 30, pp. 101413-101413
Open Access | Times Cited: 179
Effects of curcumin on mitochondria in neurodegenerative diseases
Hossein Bagheri, Faezeh Ghasemi, George E. Barreto, et al.
BioFactors (2019) Vol. 46, Iss. 1, pp. 5-20
Open Access | Times Cited: 174
The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders
Priti Tagde, Pooja Tagde, Fahadul Islam, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7109-7109
Open Access | Times Cited: 126
Encapsulation of multiple probiotics, synbiotics, or nutrabiotics for improved health effects: A review
Qingzhuo Gu, Yan Yin, Xiaojia Yan, et al.
Advances in Colloid and Interface Science (2022) Vol. 309, pp. 102781-102781
Closed Access | Times Cited: 77
Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy
Hicham Wahnou, Riad El Kebbaj, Bertrand Liagre, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 114-114
Open Access | Times Cited: 6
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Sex difference in human diseases: mechanistic insights and clinical implications
Yuncong Shi, Jianshuai Ma, Sijin Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Therapeutic potentials of curcumin in the treatment of glioblstoma
Zahra Shabaninejad, Mohammad Hossein Pourhanifeh, Ahmad Movahedpour, et al.
European Journal of Medicinal Chemistry (2020) Vol. 188, pp. 112040-112040
Closed Access | Times Cited: 59
Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders
Elisa Panzarini, Stefania Mariano, Stefano Tacconi, et al.
Nanomaterials (2020) Vol. 11, Iss. 1, pp. 2-2
Open Access | Times Cited: 59
Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways
Reza Bagherian, Rajab Mardani, Bostan Roudi, et al.
Journal of Molecular Neuroscience (2020) Vol. 70, Iss. 10, pp. 1471-1483
Closed Access | Times Cited: 58
Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas
Francesca Persano, Giuseppe Gigli, Stefano Leporatti
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3360-3360
Open Access | Times Cited: 37
Targeted co-delivery of curcumin and erlotinib by MoS2 nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer
Zhihuai Chen, Xinqi Wei, Yunru Zheng, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Curcumin-based nanomedicines: A promising avenue for brain neoplasm therapy
Mohammad Banazadeh, Behzad Behnam, Narges Ashraf Ganjooei, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105040-105040
Closed Access | Times Cited: 18
The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects
Larisa Ryskalin, Francesca Biagioni, Carla L. Busceti, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4839-4839
Open Access | Times Cited: 43
Curcumin: reclaiming the lost ground against cancer resistance
Siraj B. Shaikh, Javed Shaikh, Yusufi Sadia Naba, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 39
Nanomedicines Targeting Glioma Stem Cells
Arjun Sabu, Te‐I Liu, Siew Suan Ng, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 158-181
Closed Access | Times Cited: 26
Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target
Lorenzo Manfreda, Elena Rampazzo, Luca Persano
Biology (2023) Vol. 12, Iss. 5, pp. 729-729
Open Access | Times Cited: 14
Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
Artem Blagodatski, Antonina Klimenko, Lee Jia, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 589-589
Open Access | Times Cited: 33
Curcumin inhibits adverse psychological stress‐induced proliferation and invasion of glioma cells via down‐regulating the ERK/MAPK pathway
Ping Wang, Xinwei Hao, Xiaohan Li, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 15, pp. 7190-7203
Open Access | Times Cited: 28
Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
Ruoling Gao, Yuan Gu, Ying Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Actin-binding carbon dots selectively target glioblastoma cells while sparing normal cells
Anjana Sharma, Vineeta Panwar, Jijo Thomas, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 200, pp. 111572-111572
Closed Access | Times Cited: 24
Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death
Jin Li, Xianyanling Yi, Liangren Liu, et al.
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 1198-1215
Closed Access | Times Cited: 10
Chromobox protein homolog 7 suppresses the stem-like phenotype of glioblastoma cells by regulating the myosin heavy chain 9-NF-κB signaling pathway
Kaixiang Ni, Yuankun Liu, Di Pan, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders
Pratikeswar Panda, Sanjib Mohanty, Sangita Ranee Gouda, et al.
Nutritional Neuroscience (2025), pp. 1-26
Closed Access
Potential of Curcumin and Its Analogs in Glioblastoma Therapy
Agnieszka Nowacka, Ewa Ziółkowska, Wojciech Smuczyński, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 351-351
Open Access
Page 1 - Next Page

Scroll to top